Search clinical trials for: HIV seronegative

Total 12945 results

National Institute of Allergy and Infectious Diseases...

Completed

Safety and Immunogenicity of a Single Dose of the Recombinant Live-Attenuated Respiratory Syncytial Virus (RSV) Vaccines RSV ΔNS2/Δ1313/I1314L, RSV 6120/ΔNS2/1030s, RSV 276 or Placebo, Delivered as Nose Drops to RSV-Seronegative Children 6 to 24 Months of Age

Respiratory Syncytial Virus (RSV)

United States
University of Chicago

Active, not recruiting

Partner Services Pre-exposure Prophylaxis (PS-PrEP) (PS-PrEP)

HIV Transmission, Transtheoretical Model of Change

United States
Inovio Pharmaceuticals

Completed

VGX-3100 Delivered Intramuscularly (IM) Followed by Electroporation (EP) for the Treatment of HPV-16 and/or HPV-18 Related Anal or Anal/Peri-Anal, High Grade Squamous Intraepithelial Lesion (HSIL) in Individuals Seronegative for Human Immunodeficiency Virus (HIV)-1/2

Anal Neoplasm

United States, Canada
National Institute of Allergy and Infectious Diseases...

Completed

Evaluating the Safety and Pharmacokinetics of PC-1005 Administered Rectally to HIV-1 Seronegative Adults

HIV Infections

United States
Abivax S.A.

Completed

A Safety, Pharmacokinetics, and Pharmacodynamics Study of ABX464 in HIV-1 Seronegative and Seropositive Adults

HIV Infections | Health Volunteers

Spain
University of California, Los Angeles
Eunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaborators

Completed

Engaging Seronegative Youth to Optimize HIV Prevention Continuum

HIV | Substance Use | Mental Health | STI

United States
National Institute of Allergy and Infectious Diseases...

Completed

Evaluating the Infectivity, Safety, and Immunogenicity of Recombinant Live-Attenuated RSV Vaccines RSV ΔNS2/Δ1313/I1314L or RSV 276 in RSV-Seronegative Infants 6 to 24 Months of Age

Respiratory Syncytial Virus Infections

United States
National Institute of Allergy and Infectious Diseases...

Completed

A Phase I Safety and Immunogenicity Study of HIV p17/p24:Ty-VLP in HIV-1 Seronegative Subjects

HIV Infections

United States
National Institute of Allergy and Infectious Diseases...

Completed

Pharmacokinetic Study of Dapivirine Gel Administered Rectally to HIV-1 Seronegative Adults

HIV Infections

United States
National Institute of Allergy and Infectious Diseases...

Completed

Safety and Pharmacokinetic Study of Dapivirine Gel (0.05%) Administered Rectally to HIV-1 Seronegative Adults

HIV Infections

United States, Thailand
Radboud University Medical Center
University Medical Center Groningen; Erasmus Medical Center; Leiden University...

Withdrawn

Pharmacokinetics of Single-dose Dolutegravir in HIV-seronegative Subjects With Severe Hepatic Impairment Compared to Matched Controls. (POLO)

Hepatic Impairment | HIV-1-infection
University of California, San Diego
University of California, Los Angeles; University of Southern California; California... and other collaborators

Completed

CCTG 593: Testing and Linkage to Care

HIV Positive | HIV Seronegative

United States
Orion Biotechnology Polska Sp. z o.o.
Scope International AG

Completed

OB-002H Gel Administered Vaginally and Rectally in HIV-1 Seronegative Adults

HIV Prevention

Poland
University of Colorado, Denver

Completed

Drug Interaction Potential Between Dolutegravir and Simeprevir in HIV/HCV Seronegative Volunteers

Hepatitis C | HIV

United States
GlaxoSmithKline

Completed

Dose-ranging Study to Evaluate the Safety & Immunogenicity of a HIV Vaccine 732461 in Healthy HIV Seronegative Volunteers

HIV Infections | AIDS

Belgium
National Institute of Allergy and Infectious Diseases...

Completed

Evaluating the Infectivity, Safety and Immunogenicity of a Recombinant Live-Attenuated Respiratory Syncytial Virus Vaccine in RSV-Seronegative Infants 6 to 24 Months of Age

Respiratory Syncytial Virus Infections

United States
Hospital Italiano de Buenos Aires

Completed

Severe Impairment of Solute-Free Water Clearance in Patients With HIV Infection

HIV Infection

Argentina
International Partnership for Microbicides, Inc.
National Institute of Allergy and Infectious Diseases (NIAID); National Institutes...

Completed

Safety and Pharmacokinetic Study of Oral Maraviroc and Maraviroc 1% Gel in HIV-1 Seronegative Adults

HIV/AIDS

United States
Janssen Research & Development, LLC

Completed

A Study to Evaluate Safety, Acceptability, Pharmacokinetics, and ex Vivo Pharmacodynamics of TMC278 Long Acting Formulation in HIV-1 Seronegative Participants

Healthy

United States
National Institute of Allergy and Infectious Diseases...

Completed

Topical Metronidazole and Miconazole Co-formulated Vaginal Suppositories for Preventing Vaginal Infections in HIV-seronegative Women

Candidiasis | Bacterial Vaginosis | Trichomoniasis

United States, Kenya
HIV Vaccine Trials Network
National Institute of Allergy and Infectious Diseases (NIAID); EuroVacc Foundation

Completed

Safety of and Immune Response to Prime/Boost Vaccine Regimens in Healthy, HIV-1 Uninfected, Ad5 Seronegative Adults

HIV Infections

Switzerland
National Taiwan University Hospital

Completed

Effectiveness of Hepatitis A Virus Vaccination Among Homosexual Males at Risk for Hepatitis A Infection

Hepatitis

Taiwan
University of Washington

Withdrawn

An Open-label Trial of the Effect of Valacyclovir on Plasma HIV-1 Levels Among HIV-1 Seropositive and HSV-1/2 Seronegative Persons

HIV Infections | HIV
Kirby Institute
National Heart, Lung, and Blood Institute (NHLBI); St Vincent's Hospital, Sydney and other collaborators

Completed

Seronegatives and Metabolic Abnormalities Protocol 2 (SAMA002): Study to Compare the Effect of Kaletra and Combivir® in HIV-Negative Healthy Subjects

Glucose Metabolism Disorders | Metabolic Diseases | HIV Infections | Cardiovascular Disease | Dyslipidemias | Lipodystrophy

Australia
National Institute of Diabetes and Digestive and...

Unknown

HIV Antiretroviral Drugs and Metabolism

HIV Infections

United States
Thai Red Cross AIDS Research Centre
Walter Reed Army Institute of Research (WRAIR)

Completed

Preliminary Study of Early, Primary HIV Infection in a High Risk Cohort (SEARCH004)

HIV Infections

Thailand
National Institute of Allergy and Infectious Diseases...

Completed

A Phase I Safety and Immunogenicity Trial of UBI Multivalent HIV-1 Peptide Immunogen in HIV-1 Seronegative Human Subjects

HIV Infections

United States
National Institute of Allergy and Infectious Diseases...

Completed

A Phase I Safety and Immunogenicity Trial of UBI HIV Lipopeptide Vaccine Component P3C541b in HIV-1 Seronegative Human Subjects

HIV Infections

United States
National Institute of Allergy and Infectious Diseases...
United Biomedical

Completed

A Phase I Safety and Immunogenicity Trial of UBI Microparticulate Monovalent HIV-1 MN Peptide Immunogen in HIV-1 Seronegative Human Subjects

HIV Infections

United States
United Biomedical

Completed

A Phase I/II Safety and Immunogenicity Trial of UBI Microparticulate Monovalent (HIV-1 MN) Branched Peptide Vaccine in HIV-1 Seronegative Human Subjects

HIV Infections

United States
Chiron Corporation

Completed

A Phase I, Observer-Blind, Placebo-Controlled Study of the Chiron Vaccine HIV p24/MF59 Administered to Healthy HIV-Seronegative Adults

HIV Infections | HIV Seronegativity

United States
University of Miami
National Institute of Mental Health (NIMH)

Not yet recruiting

Joining Under-connected Networks to Optimize "Salud" (Health) ("JUNTOS")

Hiv

United States
Hookipa Biotech GmbH

Not yet recruiting

Safety, Reactogenicity and Immunogenicity of HB-502 and HB-501 Versus Placebo in People With HIV on Suppressive ART

Human Immunodeficiency Virus (HIV) Infection

United States
University of Miami
Medtronic

Not yet recruiting

STARLITE for Unresectable High-Grade Gliomas (STARLITE)

High Grade Glioma

United States
Tulane University
National Institute of Allergy and Infectious Diseases (NIAID); National Institutes...

Not yet recruiting

A Seek, Test, and Treat Intervention to Reduce Chlamydia Trachomatis Disparities

Hiv | Chlamydia | Gonorrhea | Syphilis
Cambridge University Hospitals NHS Foundation Trust

Not yet recruiting

Low-Dose IL-2 For The Reduction Of Vascular Inflammation In ACS -Clinical Outcomes & Follow-up Study (IVORY-FINALE)

Acute Coronary Syndromes

United Kingdom
Cairo University

Not yet recruiting

Efficacy and Safety of Lactoferrin in Heart Failure Patients

Heart Failure With Reduced Ejection Fraction
Belgian Research on AIDS and HIV Consortium

Not yet recruiting

Use of Long-Acting Injectable Cabotegravir/Rilpivirine for the Treatment of HIV in Belgium

Human Immunodeficiency Virus
University of California, San Francisco
National Institute of Allergy and Infectious Diseases (NIAID); University of... and other collaborators

Not yet recruiting

Randomized Trial to Optimize Virologic Suppression Rates Using a Point-of-Care Urine Monitoring Assay (ROVING PUMA) (ROVING-PUMA)

ART Adherence

South Africa
Centre Hospitalier Universitaire de Nice

Not yet recruiting

Descriptive Analysis of Changes in Hepatitis B Markers in People Living With HIV on Injectable Therapy.

Hepatitis B | Hiv Infection

France
ANRS, Emerging Infectious Diseases

Not yet recruiting

Assisted Notification of Partners of Men Having Sex With Men Discovering Their Seropositivity (NotiVIH)

HIV Infections
University of Massachusetts, Worcester
National Institute on Drug Abuse (NIDA); University of Zambia

Recruiting

Zambia Healthy Choices Project for Emerging Adults Living With HIV

Pre-Exposure Prophylaxis

Zambia
M.D. Anderson Cancer Center
RUNX1 Foundation

Recruiting

Protocol Title: Safety and Feasibility of Autologous CD34+ Hematopoietic Stem Cells Mobilization and Apheresis in Participants With RUNX1 Familial Platelet Disorder

RUNX1 Familial Platelet Disorder

United States
University of Massachusetts, Amherst
University of California, San Francisco; RAND; Universidad Autonoma de Santo... and other collaborators

Not yet recruiting

Urban Gardening and Peer Nutritional Counseling for People With HIV and Food Insecurity (ProMeSA)

HIV | Food Insecurity
All India Institute of Medical Sciences, Bhubaneswar

Not yet recruiting

Study on Efficacy of Add on Selenium in Mild-to-moderate Graves Ophthalmopathy

Thyroid Eye Disease | Graves Ophthalmopathy

India
Yale University
ViiV Healthcare

Not yet recruiting

Pharmacist-led Intervention for Injectable HIV Treatment for Women With Health-related Social Needs

Hiv

United States
King's College London

Not yet recruiting

Inflammation in Acute Cardiovascular Diseases - the CArdiovascular Inflammation Registry (CAIR) (CAIR)

Myocardial Infarction | Heart Diseases | Cardiovascular Diseases | Heart Failure | Inflammation | Myocarditis | Pericarditis
Friends Research Institute, Inc.
Weill Medical College of Cornell University

Recruiting

Optimal Intervention to Full Viral Suppression: Text Me, Alexis!

HIV

United States
University Hospital, Basel, Switzerland

Not yet recruiting

Safety and Modulation of Adaptive Immunity by Iscador® Qu Viscum Album Extract in Patients With Advanced, Recurrent or Metastatic Cancers Treated With Immune Checkpoint Inhibitors (ISCA-CHECK)

Advanced Solid Tumor

Switzerland
Bill & Melinda Gates Medical Research Institute

Not yet recruiting

Study To Evaluate Safety, Tolerability, and Pharmacokinetics of MAM01 in African Population

Healthy Volunteers

Kenya, Uganda

Search clinical trials for: HIV seronegative

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Albania

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations